Finance

Beta
Lists
049960:KOSDAQ
Cell Biotech Co Ltd
â‚©16,330.00
-3.37%
(-570.00) 1D
Jun 5, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 049960...
Open
â‚©16,760
High
â‚©16,760
Low
â‚©16,030
Mkt. cap
153.50B
Avg. vol.
31.13K
Volume
21.54K
Dividend
3.67%
Quarterly dividend
â‚©150
Ex-dividend date
Dec 27, 2023
P/E ratio
8.34
52-wk high
â‚©18,500
52-wk low
â‚©11,350
EPS
â‚©1,959
Shares outstanding
9.40M
No. of employees
101
Open
â‚©16,760
High
â‚©16,760
Low
â‚©16,030
Mkt. cap
153.50B
Avg. vol.
31.13K
Volume
21.54K
Dividend
3.67%
Quarterly dividend
â‚©150
Ex-dividend date
Dec 27, 2023
P/E ratio
8.34
52-wk high
â‚©18,500
52-wk low
â‚©11,350
EPS
â‚©1,959
Shares outstanding
9.40M
No. of employees
101
News stories
From sources across the web
About Cell Biotech Co Ltd
CEOMyung-jun Chung
Employees101
Founded1995
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
11.91B
15.36B
14.63B
14.60B
Cost of goods sold
3.08B
4.42B
3.98B
3.99B
Cost of revenue
3.08B
4.42B
3.98B
3.99B
Research and development expenses
1.07B
846.82M
941.81M
988.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.81B
7.22B
6.03B
5.78B
Operating expense
7.55B
8.72B
7.60B
7.42B
Total operating expenses
10.63B
13.14B
11.58B
11.41B
Operating income
1.28B
2.22B
3.05B
3.19B
Other non operating income
54.34M
46.11M
61.38M
43.33M
EBT including unusual items
65.93M
4.10B
4.68B
6.62B
EBT excluding unusual items
-282.81M
4.17B
4.52B
6.62B
Income tax expense
-147.53M
648.29M
290.10M
1.27B
Effective tax rate
-223.76%
15.82%
6.19%
19.19%
Other operating expenses
55.81M
49.84M
40.45M
41.09M
Net income
213.46M
3.45B
4.39B
5.35B
Net profit margin
1.79%
22.46%
30.02%
36.66%
Earnings per share
-
-
-
-
Interest and investment income
701.58M
689.61M
691.29M
658.74M
Interest expense
-8.90M
-7.37M
-5.68M
-4.23M
Net interest expenses
692.68M
682.24M
685.61M
654.51M
Depreciation and amortization charges
538.85M
537.83M
544.32M
557.83M
EBITDA
2.18B
3.11B
3.95B
4.09B
Gain or loss from assets sale
-32.57M
2.00K
170.99M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more